⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

October 20, 2025Open Access

Table 2 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Chi M. Nguyen Paul G. Yeh Mai P. Nguyen Travis S. Johnson Hyunwoo Koo Victoria L. Champion Todd C. Skaar David R. Lairson Patrick O. Monahan Thomas F. Imperiale Hongmei Nan

View Full Paper

Ask AI

Bookmark

Share

Key Points

Higher medical and prescription costs are associated with metastatic colorectal cancer compared to nonmetastatic cases.
Out-of-pocket expenses significantly impact patient financial burden, emphasizing the need for better cost management.
Investigating treatment components reveals variable costs across different care settings, indicating care disparities.
Understanding these costs can inform patient care strategies and policy decisions to improve cancer treatment access.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Analysis compares medical and prescription costs in metastatic colorectal cancer patients, suggesting high out-of-pocket expenses.

Abstract

Medical service charges and OOP expenses by core treatment components and care settings (in $2023).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nguyen et al. (2025) studied this question.

synapsesocial.com/papers/68f83319d24b29c969481914 https://doi.org/10.1158/2767-9764.30399541

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Table 3 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
2Table S2 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
3Figure 3 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
4Table S3 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
5Table S4 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
6Table S6 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
7Figure 2 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025
8Figure 4 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer2025